News and insights
The ESG tightrope: balancing risk, profit, policy, and purpose
In our third episode, we examine the challenges businesses face in integrating ESG into their strategy while navigating regulatory pressures, stakeholder expectations, and financial performance. Featuring Siân Skelton, Partner at Taylor Wessing, and Dame Inga Beale, former CEO of Lloyd’s of London and a leading advocate for diversity and responsible business.
GPAI Code of Practice - Third Draft: Changes to the requirements for copyright compliance
New product liability risks for AI products
The new Product Liability Directive aims to modernise the product liability rules and remove obstacles for consumers. What should life sciences companies using AI in products know about the new product liability rules.
5 / 10 观点
Purpose limitation and data minimisation: key considerations for AI training in the life sciences sector
The use of real-world evidence data to train AI models is becoming a critical component in advancing research and drug development. We explore how two of the GDPR's guiding principles are more than just regulatory requirements.
3 / 10 观点
UK approach to regulating AI in Life Sciences
As AI innovation in the life sciences sector continues at pace, the Medicines and Healthcare products Regulatory Agency (MHRA) publishes principles and guidance in relation to software-as-a-medical-device which includes the application of AI.
1 / 10 观点
